NCT00589225View on ClinicalTrials.gov

Primary Hyperoxaluria Mutation Genotyping

CompletedOBSERVATIONAL
Enrollment

902

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Primary Hyperoxaluria
Interventions
GENETIC

Genetic Analysis

We will draw one tube of blood from your arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic testing.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Oxalosis and Hyperoxaluria Foundation (OHF)

OTHER

lead

Mayo Clinic

OTHER